Skip to content

The role of gut microbiota and chronic inflammation as drivers of cardiovascular disease - Nijmegen Biomedical Study - Non Invasive markers of Atherosclerosis 3

The role of gut microbiota and chronic inflammation as drivers of cardiovascular disease - Nijmegen Biomedical Study - Non Invasive markers of Atherosclerosis 3 - NBS-NIMA3

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38378
Enrollment
500
Registered
2014-04-28
Start date
2014-05-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis cardiovascular disease

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - participant NIMA-NBS 2 study - body mass index > 27 kg/m2

Exclusion criteria

Exclusion criteria: - Recent cardiovascular event (myocardial infarction, transient ischemic attack, stroke 1.6) - Renal dysfunction (estimated glomerular filtration rate

Design outcomes

Primary

MeasureTime frame
Descriptive data: Questionnaires DNA: Gene polymorphisms at DNA level Transcriptome: RNA expression in blood and adipose tissue Metabolome: Small molecule metabolites in blood en urine Microbiome: Presence of groups of bacteria Phenotype: Measures of atherosclerosis, adiposity, hepatic steatosis Functional data: Cytokine production by adipocytes, monocytes Follow-up data: Cardiovascular events registry

Secondary

MeasureTime frame
-

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 9, 2026